Lv2
146 积分 2022-02-28 加入
P1.07.39 Pooled Efficacy and Safety Profile of Neoadjuvant Therapies in Operable EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis
17小时前
求助中
Rare EGFR E709-T710delinsX: Molecular characteristics and superior response to afatinib treatment in NSCLC patients
15天前
已完结
Effect of furmonertinib on the pharmacokinetics of rivaroxaban or apixaban in vivo
1个月前
已完结
Germline alterations in patients with lung cancer
1个月前
已完结
High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer Consortium
1个月前
已完结
Molecular subtyping of small-cell lung cancer in clinical practice: Primary tumor–lymph node concordance, intratumoral heterogeneity, and genomic context in a Chinese cohort
1个月前
已完结
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration
1个月前
已完结
Treatment patterns of elderly patients with limited-stage small-cell lung cancer in real-world data: A multicentre retrospective analysis
1个月前
已完结
Immunotherapy rechallenge in Extensive-Stage small cell lung Cancer: A Real-World retrospective study
1个月前
已关闭
NSCLC: Five trials to watch
1个月前
已完结
皖公网安备34019202002308
